A Study of the Real-life Management of Psoriatic Arthritis Patients Treated With Otezla® (Apremilast) in Belgium

Clinical trial NCT03096990 · COMPLETED

Trial details

NCT number: NCT03096990
Sponsor: Amgen
Status: COMPLETED
Study type: OBSERVATIONAL

Arthritis, Psoriatic

Start date: 2017-04-21
Primary completion: 2018-12-27
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.